Trials / Completed
CompletedNCT03158233
Zika Case Definition and Surveillance Study
Prospective Surveillance and Case Definition Study of Zika Virus Disease and Infection in Adolescents and Adults in Latin America in Preparation for an Efficacy Trial of a Zika Virus Whole Virion, Purified Inactivated Vaccine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,400 (actual)
- Sponsor
- Sanofi Pasteur, a Sanofi Company · Industry
- Sex
- All
- Age
- 15 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This prospective, surveillance study will assess the operational Zika virus definition for use in future Zika purified inactivated virus (ZIKV) vaccine efficacy trials in order to identify Zika virus disease (ZVD) cases among the study cohort.
Detailed description
This prospective, multicenter, cohort study will conduct active and passive surveillance for ZVD and determine its prevalence and seroconversion incidence in areas of Latin America experiencing Zika epidemic activity. A description of the occurrence of dengue virus and chikungunya virus infections in the cohort may also be provided as differential diagnosis of ZVD.
Conditions
Timeline
- Start date
- 2017-04-29
- Primary completion
- 2018-12-19
- Completion
- 2018-12-19
- First posted
- 2017-05-18
- Last updated
- 2022-04-25
Locations
6 sites across 4 countries: Colombia, Honduras, Mexico, Puerto Rico
Source: ClinicalTrials.gov record NCT03158233. Inclusion in this directory is not an endorsement.